Jennison Associates LLC Biogen Inc. Transaction History

Jennison Associates LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 26, 2023	BUY	$256.56 - $292.34 $15.9 Million - $18.1 Million	61,787 New	61,787 $17.2 Million
Q2 2021 Aug 12, 2021	SELL	$259.0 - $414.71 $17.1 Million - $27.3 Million	-65,838 Closed	0 $0
Q1 2021 May 11, 2021	BUY	$242.95 - $284.63 $7.79 Million - $9.13 Million	32,082 Added 95.04%	65,838 $18.4 Million
Q4 2020 Feb 05, 2021	BUY	$236.26 - $355.63 $7.98 Million - $12 Million	33,756 New	33,756 $8.27 Million
Q2 2020 Aug 06, 2020	SELL	$258.66 - $342.55 $23.6 Million - $31.3 Million	-91,368 Closed	0 $0
Q1 2020 May 06, 2020	BUY	$268.85 - $341.04 $24 Million - $30.5 Million	89,297 Added 4311.78%	91,368 $28.9 Million
Q4 2019 Feb 07, 2020	SELL	$220.06 - $304.07 $255,489 - $353,025	-1,161 Reduced 35.92%	2,071 $615,000
Q2 2019 Aug 06, 2019	SELL	$219.29 - $241.72 $21,929 - $24,172	-100 Reduced 3.0%	3,232 $0
Q1 2019 May 10, 2019	BUY	$216.71 - $338.96 $722,077 - $1.13 Million	3,332 New	3,332 $788,000
Q2 2018 Aug 02, 2018	SELL	$257.52 - $306.91 $59.4 Million - $70.8 Million	-230,771 Closed	0 $0
Q1 2018 Apr 20, 2018	BUY	$260.13 - $367.91 $27.5 Million - $38.8 Million	105,530 Added 84.26%	230,771 $63.2 Million
Q4 2017 Jan 25, 2018	BUY	$307.64 - $344.58 $8.56 Million - $9.59 Million	27,827 Added 28.57%	125,241 $39.9 Million
Q3 2017 Nov 03, 2017	BUY	$281.15 - $329.69 $27.4 Million - $32.1 Million	97,414	97,414 $30.5 Million

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Jennison Associates LLC, based on Form 13F filings with the SEC.

Stay updated on Jennison Associates LLC with notifications on news.